May 14, 2021
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers…
Pharmaceuticals, Biotechnology and Life Sciences
DAVIS, Calif., May 13, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers…
Highly experienced executives, Dr. Dennis Kim as Chief Medical Officer and Lewis Stuart as Chief Commercial Officer, strengthen the management…
As part of the agreement, Biogen will leverage Envisagenics’ AI platform with the goal of better understanding Central Nervous System…
—Requested Meeting with FDA to Discuss Next Steps in Development of CAP-1002 for Duchenne Muscular Dystrophy- -Data for Phase II…
CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
Data from Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis expected in the third quarter. Preclinical data for IND…
4D-150 designed as an intravitreal gene therapy with dual transgenes expressing aflibercept and VEGF-C RNAi for the treatment of wet…
Median Duration of Response Not Reached at 18.7 Months of Median Study Follow Up C-144-01 Study Contributes to Advancement in…
BRIDGEWATER, N.J., May 12, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated…
LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) — Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies…